Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million

Go back to Axsome Therapeutics reports preliminary 2025 revenue of $638.5 million
(NASDAQ: AXSM) Delayed: 202.83 --0 (-0%)
Previous Close $202.83    52 Week High $15.74 
Open $202.83    52 Week Low $5.37 
Day High $202.83    P/E N/A 
Day Low $202.83    EPS $0.00 
Volume 50